Citizens JMP raised the firm’s price target on Hippo (HIPO) to $40 from $35 and keeps an Outperform rating on the shares. The company reported strong Q2 results and achieved net income positivity for the first time, the analyst tells investors in a research note. The firm believes Hippo shares are attractively valued at current levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIPO: